- Home
- OABI vs CRMT Comparison
OABI vs CRMT Comparison
Compare OABI & CRMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- CRMT
- Stock Information
- Founded
- OABI 2012
- CRMT 1981
- Country
- OABI United States
- CRMT United States
- Employees
- OABI N/A
- CRMT N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- CRMT Other Specialty Stores
- Sector
- OABI Health Care
- CRMT Consumer Discretionary
- Exchange
- OABI Nasdaq
- CRMT Nasdaq
- Market Cap
- OABI 239.0M
- CRMT 266.5M
- IPO Year
- OABI N/A
- CRMT N/A
- Fundamental
- Price
- OABI $1.58
- CRMT $19.64
- Analyst Decision
- OABI Strong Buy
- CRMT Buy
- Analyst Count
- OABI 3
- CRMT 1
- Target Price
- OABI $6.67
- CRMT $45.00
- AVG Volume (30 Days)
- OABI 544.6K
- CRMT 160.6K
- Earning Date
- OABI 11-04-2025
- CRMT 12-04-2025
- Dividend Yield
- OABI N/A
- CRMT N/A
- EPS Growth
- OABI N/A
- CRMT N/A
- EPS
- OABI N/A
- CRMT 1.61
- Revenue
- OABI $21,094,000.00
- CRMT $1,378,681,000.00
- Revenue This Year
- OABI N/A
- CRMT $3.49
- Revenue Next Year
- OABI $48.89
- CRMT $5.72
- P/E Ratio
- OABI N/A
- CRMT $12.09
- Revenue Growth
- OABI 3.36
- CRMT 0.64
- 52 Week Low
- OABI $1.22
- CRMT $19.20
- 52 Week High
- OABI $4.61
- CRMT $62.72
- Technical
- Relative Strength Index (RSI)
- OABI 49.87
- CRMT 25.52
- Support Level
- OABI $1.33
- CRMT $19.20
- Resistance Level
- OABI $1.64
- CRMT $19.95
- Average True Range (ATR)
- OABI 0.09
- CRMT 1.03
- MACD
- OABI 0.01
- CRMT 0.02
- Stochastic Oscillator
- OABI 55.92
- CRMT 7.68
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About CRMT America's Car-Mart Inc
America's Car-Mart Inc is an automotive retailer in the U.S. focused exclusively on the Integrated Auto Sales and Finance segment of the used car market. The company's operations are principally conducted through its two operating subsidiaries, America's Car Mart Inc and Colonial Auto Finance. It predominantly sells older model used vehicles and provides financing for substantially all of its customers. It earns revenue from the sale of used vehicles and, in the majority of cases, a related service contract and an accident protection plan product, as well as interest income and late fees from the related financing.